Search Results 1611-1620 of 17441 for magnesiummagnesium

  1. A Study to Compare Intralipid Versus SMOFlipid in New Home Parenteral Nutrition (HPN) Patients - Mayo Clinic

    Severe hyperlipidemia or severe disorders of lipid metabolism with serum triglycerides > 1,000 mg/dL. Participating Mayo Clinic locations. Study statuses ...

  2. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

    Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or interpretation of results ...

  3. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

    Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or interpretation of results ...

  4. A Study of the Effects of Aliskiren in Patients with Idiopathic Membranous Nephropathy - Mayo Clinic

    Participation eligibility · Age <18 years · Estimated Glomerular Filtration Rate (GFR) < 30 ml/min/1.73m^2, or serum creatinine >3.0 mg/dl · Must be off prednisone ...

  5. Migalastat (oral route) - Side effects & dosage - Mayo Clinic

    For Fabry disease: Adults—123 milligrams (mg) once every other day at the same time of day. Children—Use and dose must be determined by ...

  6. Publications - Ming Yang, M.D. - Mayo Clinic

    Hemorrhage rates and outcomes when using up to 100 mg intra-arterial t-PA for thrombolysis in acute ischemic stroke. Interv Neuroradiol. 2010 Sep; 16(3):297 ...

  7. Publications - Brittany L. Siontis, M.D. - Mayo Clinic

    ... MG, Petersen IA. Hypofractionated Preoperative Radiation Therapy for Extremity and Superficial Trunk Soft Tissue Sarcomas: Results of a Prospective, Phase 2 ...

  8. A Study to Assess the Effectiveness and Safety of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

    The purpose of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over ...

  9. A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis - Mayo Clinic

    Current or previous (within the previous 6 months) use ofDMARDs – prednisone (≥ 10 mg/day), methotrexate,hydroxychloroquine, sulfasalazine, leflunomide ...

  10. Pilot Study on FDG PET/MRE for Stricture Assessment in Crohn’s Disease - Mayo Clinic

    At the discretion of the PI and the authorized user and with their approval prior to FDG injection, subjects with blood glucose ≥ 200 mg/dL may participate in ...